Concentrations of Zt/g4-DM1 ( μ g/ml)

1
Concentrations of Zt/g4-DM1 (μg/ml) Cell viability (% of control) Feng et al. Supplementary Fig 2: IC 50 for DLD1 (μg/ml) CmIgG-DM1: not calculated Zt/g4-DM1: 20.36 Zt/c1-DM1: 21.14 IC 50 for LoVo (μg/ml) CmIgG-DM1: not reached Zt/g4-DM1: not reached Zt/c1-DM1: not reached Caption: Effect of anti-RON ADCs in vitro on reduction of viability of CRC cells expressing no or low levels of RON.

description

Caption: Effect of anti-RON ADCs in vitro on reduction of viability of CRC cells expressing no or low levels of RON. Cell viability (% of control). IC 50 for LoVo ( μ g/ml) CmIgG-DM1: not reached Zt/g4-DM1: not reached Zt/c1-DM1: not reached. IC 50 for DLD1 ( μ g/ml) - PowerPoint PPT Presentation

Transcript of Concentrations of Zt/g4-DM1 ( μ g/ml)

Page 1: Concentrations of Zt/g4-DM1 ( μ g/ml)

Concentrations of Zt/g4-DM1 (μg/ml)

Ce

ll v

iab

ilit

y (

% o

f c

on

tro

l)

Feng et al. Supplementary Fig 2:

IC50 for DLD1 (μg/ml) CmIgG-DM1: not calculated Zt/g4-DM1: 20.36 Zt/c1-DM1: 21.14

IC50 for LoVo (μg/ml) CmIgG-DM1: not reached Zt/g4-DM1: not reached Zt/c1-DM1: not reached

Caption: Effect of anti-RON ADCs in vitro on reduction of viability of CRC cells expressing no or low levels of RON.